Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kamesaki H is active.

Publication


Featured researches published by Kamesaki H.


Cancer | 1988

Malignant histiocytosis with rearrangement of the heavy chain gene and evidence of monocyte—macrophage lineage

Kamesaki H; Mitsuhiko Koya; Hiroshi Miwa; Kenkichi Kita; Shoichi Doi; Eiji Tatsumi; Masakazu Hatanaka; Haruto Uchino

A unique case of malignant histiocytosis (MH) is reported. Its origin from the monocyte—macrophage system was indicated by expression of highly specific myeloid cell markers (My4, MCS2, and cytoplasmic lysozyme), diffuse activity of acid phosphatase and NaF‐sensitive α‐naphthyl acetate esterase, lack of immunologic markers specific for other cell lineages, and germ line configuration of the immunoglobulin light chain gene and the T‐cell receptor β‐chain gene. Its neoplastic nature was suggested by the single rearranged band of the immunoglobulin heavy chain gene.


Japanese Journal of Cancer Research | 1988

A Novel B Cell Line Established from Ki-1-positive Diffuse Large Cell Lymphoma

Kamesaki H; Hiroshi Miwa; Yohichiro Ohno; Setsuko Miyanishi; Hirohiko Yamabe; Shoichi Doi; Yu Arita; Hitoshi Ohno; Eiji Tatsumi; Masaru Nishikori; Shirou Fukuhara; Masakazu Hatanaka; H Uchino

A novel cell line, designated KIS‐1, was established from a patient with Ki‐1‐positive diffuse large cell lymphoma. Multiple phenotypic analysis of the KIS‐1 cells was carried out with a total of 22 monoclonal antibodies defining hematopoietic cell subsets and lineages. The KIS‐1 cells were positive for Ki‐1, B4, HLA‐DR, and 2D1 (common leucocyte) antigens, but were negative for the antigens reportedly specific for T cells, natural killer cells, granulocytes, monocytes, interdigitating reticulum cells and dendritic reticulum cells. The genomic analysis of the KIS‐1 cells showed not only the rearrangement of JH and Jk genes but also the probable rearrangement of Cγ genes. Moreover, the cells produced immunoglobulin γ chains. Thus, KIS‐1 was considered to be of B‐cell lineage. The lymphoma‐cell derivation of KIS‐1 was based on the following facts. The cytochemical, immunologic, cytogenetic properties and the results of the molecular genomic analysis in the KIS‐1 cells were essentially the same as those of the original tumor cells, and the KIS‐1 cells were negative for Epstein‐Barr virus‐associated nuclear antigen. KIS‐1 is the only known B‐cell line derived from Ki‐1‐positive diffuse large cell lymphoma, and should be useful for defining the biological implications of Ki‐1 antigen.


Recent results in cancer research | 1989

A New Hypothesis on the Cellular Origin of Reed-Sternberg and Hodgkin Cells Based on the Immunological and Molecular Genetic Analysis of the KM-H2 Line

Kamesaki H; Shirou Fukuhara; H Uchino; Tetsuya Nosaka

Previously we reported a novel cell line, KM-H2, established from the pleural effusion of a patient who was initially diagnosed as having Hodgkin’s of mixed cellular type (Kamesaki et al. 1986). We describe here the results of further investigation of this line (ultrastructural, immunological, and molecular genetic studies) and discuss its cellular origin. Based on these analyses of the KM-H2 line, as well as those of other cell lines derived from Reed-Sternberg and Hodgkin cells (e.g., L428, L540), we propose a new hypothesis for the cellular origin of Hodgkin’s disease.


Blood | 1986

Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease

Kamesaki H; Shirou Fukuhara; Eiji Tatsumi; H Uchino; Hirohiko Yamabe; Hiroshi Miwa; Shigeru Shirakawa; Masakazu Hatanaka; Tasuku Honjo


Proceedings of the National Academy of Sciences of the United States of America | 1990

Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen

Hitoshi Ohno; Takahisa Furukawa; Shirou Fukuhara; Shu Qin Zong; Kamesaki H; Thomas B. Shows; M. M. Le Beau; T. W. Mckeithan; T. Kawakami; Tasuku Honjo


Blood | 1985

Phenotypic analysis of acute lymphoblastic leukemia (ALL) cells which are classified as non-T non-B and negative for common ALL antigen

Kenkichi Kita; Kaori Nasu; Kamesaki H; Shoichi Doi; H Tezuka; Eiji Tatsumi; Shirou Fukuhara; Masaru Nishikori; H Uchino; Shigeru Shirakawa


American Journal of Clinical Pathology | 1989

Immunohistochemical Analysis of Peripheral T-Cell Lymphoma in Japanese Patients

Shoichi Doi; Kaori Nasu; Yuu Arita; Satoru Tanabe; Fumio Matsuyama; Kamesaki H; Shirou Fukuhara; Masaru Nishikori; Hiroshi Miwa; Kenkichi Kita; Masakazu Hatanaka; Haruto Uchino


Blood | 1987

Lymphoma cell line (FL-18) and Epstein-Barr virus-carrying cell line (FL-18-EB) obtained from a patient with follicular lymphoma: monoclonal derivation and different properties

Shoichi Doi; Hitoshi Ohno; Eiji Tatsumi; Yuu Arita; Kamesaki H; Shirou Fukuhara; Masaru Nishikori; Hiroshi Miwa; Kenkichi Kita; Masakazu Hatanaka


Journal of Japan Haematological Society | 1986

Blast crisis in chronic myelocytic leukemia with blasts expressing both lymphoid and myeloid antigens.

Kenkichi Kita; Tezuka H; Kamesaki H; Shoichi Doi; Nasu K; Tatsumi E; Nishikori M; Haruto Uchino; Tomono N; Tanaka S


Journal of Japan Haematological Society | 1985

Phenotypic characterization and clinical evaluation of 15 patients with lymphoblastic lymphoma.

Kenkichi Kita; Nasu K; Kamesaki H; Shoichi Doi; Tezuka H; Sawada H; Fukuhara S; Nishikori M; Haruto Uchino; Fukumoto M

Collaboration


Dive into the Kamesaki H's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Miwa

Aichi Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge